Inhibition of Granzyme B by PI-9 protects prostate cancer cells from apoptosis

Prostate

Volumn 72, Issue 8, 2012, Pages 846-855

  Ray, Manisha ^a   Hostetter, Daniel R ^a   Loeb, Carly R K ^a   Simko, Jeffry ^a   Craik, Charles S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apoptosis; Granzyme B; immunosurveillance; PI 9; prostate cancer

Indexed keywords

GRANZYME B; PI 9; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GRADING; CELL PROTECTION; CELL STRAIN LNCAP; ENZYME INHIBITION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; APOPTOSIS; CELL LINE, TUMOR; DISEASE PROGRESSION; GRANZYMES; HUMANS; MALE; PROSTATIC NEOPLASMS; SERPINS; UP-REGULATION;

EID: 84860347861     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21486     Document Type: Article

References (33)

1. Russell JH, Ley TJ,. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20: 323-370. (Pubitemid 34293428)
2. Rawlings ND, Morton FR, Kok CY, Kong J, Barrett AJ,. MEROPS: The peptidase database. Nucleic Acids Res 2008; 36 (Database issue): D320-D325. (Pubitemid 351149743)
3. Yang X, Stennicke HR, Wang B, Green DR, Jänicke RU, Srinivasan A, Seth P, Salvesen GS, Froelich CJ,. Granzyme B mimics apical caspases. Description of a unified pathway for trans-activation of executioner caspase-3 and -7. J Biol Chem 1998; 273 (51): 34278-34283. (Pubitemid 29008904)
4. Medema JP, Toes RE, Scaffidi C, Zheng TS, Flavell RA, Melief CJ, Peter ME, Offringa R, Krammer PH,. Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis. Eur J Immunol 1997; 27 (12): 3492-3498. (Pubitemid 28018048)
5. Anthony DA, Andrews DM, Watt SV, Trapani JA, Smyth MJ,. Functional dissection of the granzyme family: Cell death and inflammation. Immunol Rev 2010; 235 (1): 73-92.
6. Lieberman J,. The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal. Nat Rev Immunol 2003; 3 (5): 361-370. (Pubitemid 37323196)
7. Lefrançois L, Obar JJ,. Once a killer, always a killer: From cytotoxic T cell to memory cell. Immunol Rev 2010; 235 (1): 206-218.
8. Hanahan D, Weinberg RA,. Hallmarks of cancer: The next generation. Cell 2011; 144 (5): 646-674.
9. Kaiserman D, Bird PI,. Control of granzymes by serpins. Cell Death Differ 2010; 17 (4): 586-595.
10. Bird PI,. Serpins and regulation of cell death. Results Probl Cell Differ 1998; 24: 63-89.
11. Bladergroen BA, Strik MCM, Bovenschen N, van Berkum O, Scheffer GL, Meijer CJLM, Hack CE, Kummer JA,. The Granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J Immunol 2001; 166 (5): 3218-3225. (Pubitemid 33117320)
12. Buzza MS, Hirst CE, Bird CH, Hosking P, McKendrick J, Bird PI,. The Granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell Immunol 2001; 210 (1): 21-29. (Pubitemid 32756938)
13. Medema JP, de Jong J, Peltenburg LT, Verdegaal EM, Gorter A, Bres SA, Franken KL, Hahne M, Albar JP, Melief CJ, Offringa R,. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci USA 2001; 98 (20): 11515-11520. (Pubitemid 32928760)
14. Cunningham TD, Jiang X, Shapiro DJ,. Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity. Cell Immunol 2007; 245 (1): 32-41. (Pubitemid 46805070)
15. Jiang X, Orr BA, Kranz DM, Shapiro DJ,. Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells. Endocrinology 2006; 147 (3): 1419-1426. (Pubitemid 43244376)
16. ten Berge RL, Oudejans JJ, Ossenkoppele GJ, Meijer CJLM,. ALK-negative systemic anaplastic large cell lymphoma: Differential diagnostic and prognostic aspectsâA review. J Pathol 2003; 200 (1): 4-15. (Pubitemid 36592630)
17. Oudejans JJ, Harijadi H, Kummer JA, Tan IB, Bloemena E, Middeldorp JM, Bladergroen B, Dukers DF, Vos W, Meijer CJLM,. High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent. J Pathol 2002; 198 (4): 468-475. (Pubitemid 35447000)
18. Jiang X, Ellison SJ, Alarid ET, Shapiro DJ,. Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 2007; 26 (28): 4106-4114. (Pubitemid 46920175)
19. van Houdt IS, Oudejans JJ, van den Eertwegh AJM, Baars A, Vos W, Bladergroen BA, Rimoldi D, Muris JJF, Hooijberg E, Gundy CM, Meijer CJLM, Kummer JA,. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma. Clin Cancer Res 2005; 11 (17): 6400-6407. (Pubitemid 41262972)
20. Harzstark AL, Small EJ,. Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge). Expert Opin Biol Ther 2007; 7 (8): 1275-1280. (Pubitemid 47305251)
21. Small EJ, Schellhammer PF, Higano CS, Redfern CH, Nemunaitis JJ, Valone FH, Verjee SS, Jones LA, Hershberg RM,. Placebo-controlled phase III trial of immunologic therapy with Sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J Clin Oncol 2006; 24 (19): 3089-3094. (Pubitemid 46638945)
22. Harris JL, Peterson EP, Hudig D, Thornberry NA, Craik CS,. Definition and redesign of the extended substrate specificity of Granzyme B. J Biol Chem 1998; 273 (42): 27364-27373. (Pubitemid 28500453)
23. Shi L, Keefe D, Durand E, Feng H, Zhang D, Lieberman J,. Granzyme B binds to target cells mostly by charge and must be added at the same time as perforin to trigger apoptosis. J Immunol 2005; 174 (9): 5456-5461. (Pubitemid 40593185)
24. Willoughby CA, Bull HG, Garcia-Calvo M, Jiang J, Chapman KT, Thornberry NA,. Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis. Bioorg Med Chem Lett 2002; 12 (16): 2197-2200. (Pubitemid 34804398)
25. Mahrus S, Craik CS,. Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells. Chem Biol 2005; 12 (5): 567-577. (Pubitemid 40727931)
26. Wu JD, Higgins LM, Steinle A, Cosman D, Haugk K, Plymate SR,. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest 2004; 114 (4): 560-568. (Pubitemid 39572106)
27. De Nunzio C, Kramer G, Marberger M, Montironi R, Nelson W, Schröder F, Sciarra A, Tubaro A,. The controversial relationship between benign prostatic hyperplasia and prostate cancer: The role of inflammation. Eur Urol 2011; 60 (1): 106-117.
28. Borowsky AD, Dingley KH, Ubick E, Turteltaub KW, Cardiff RD, DeVere-White R,. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia 2006; 8 (9): 708-715. (Pubitemid 44465522)
29. Kannan-Thulasiraman P, Shapiro DJ,. Modulators of inflammation use nuclear factor-ÎB and activator protein-1 sites to induce the caspase-1 and Granzyme B inhibitor, proteinase inhibitor 9. J Biol Chem 2002; 277 (43): 41230-41239. (Pubitemid 35215715)
30. Lanier LL,. On guardâActivating NK cell receptors. Nat Immunol 2001; 2 (1): 23-27.
31. Raulet DH,. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3 (10): 781-790. (Pubitemid 37328656)
32. Liu G, Atteridge CL, Wang X, Lundgren AD, Wu JD,. The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases. J Immunol 2010; 184 (7): 3346-3350.
33. Mahrus S, Kisiel W, Craik CS,. Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B. J Biol Chem 2004; 279 (52): 54275-54282. (Pubitemid 40053165)